US Patent 11648317 Stable anti-CD79B immunoconjugate formulations
Patent 11648317 was granted and assigned to Genentech on May, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Ankit R. Patel0
Jun Liu0
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+211 characters)
US Patent 11648317 Stable anti-CD79B immunoconjugate formulations
Article
The disclosure provides stable pharmaceutical compositions comprising an anti-CD79b immunoconjugate and a surfactant. The disclosure also provides methods for using such compositions for the treatment of cancer.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116483170
Date of Patent
May 16, 2023
0Patent Application Number
163834780
Date Filed
April 12, 2019
0Patent Primary Examiner
Find more entities like US Patent 11648317 Stable anti-CD79B immunoconjugate formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.